Nureca Limited has received warning letters from both BSE Limited and National Stock Exchange of India Limited for failing to comply with mandatory committee meeting requirements under SEBI regulations. The company disclosed this development on January 07, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Non-Compliance Details

The warning letters were issued for the company's failure to hold any meeting of the Stakeholder's Relationship Committee during the Financial Year ended 2024-25. This constitutes a violation of Regulation 20(3A) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which specifically mandates that the stakeholders relationship committee shall meet at least once in a financial year.

Exchange Communications

BSE Limited issued its warning letter on January 06, 2026, stating that the non-compliance has been viewed seriously. The exchange advised the company to exercise greater diligence and take immediate corrective measures to prevent recurrence of such lapses. BSE emphasized the imperative to ensure strict adherence to all applicable exchange circulars, guidance notes, and communications.

National Stock Exchange of India Limited followed with its warning letter on January 07, 2026. NSE warned the company and advised it to be careful in future, exercise due caution, and initiate corrective steps to avoid recurrence of such lapses to ensure due compliance with SEBI LODR and exchange communications.

Regulatory Requirements and Next Steps

Both exchanges have mandated specific actions from Nureca Limited:

• Dissemination of the warning letters on all stock exchanges where the company is listed
• Presentation of the warning letters before the Board of Directors
• Implementation of corrective measures to avoid future lapses
• Ensuring strict compliance with all applicable regulations

Both BSE and NSE have clearly stated that any future deviation will be viewed with utmost seriousness and may attract appropriate action as deemed necessary. The exchanges have emphasized the need for the company to ensure due compliance with SEBI LODR regulations and exchange communications going forward.

Company Response

The disclosure was signed by Nishu Kansal, Company Secretary & Compliance Officer (M.No. A33372), on January 07, 2026. The company has acknowledged receipt of both warning letters and confirmed that there is no quantifiable financial impact from this regulatory action on the company's financial, operational, or other activities.

Nureca Limited , a healthcare and wellness products company, has published its post-buyback public announcement following the Board's approval of a ₹19.14 crore share buyback program, completing key regulatory requirements under SEBI Buyback Regulations.

Buyback Program Details

The Board of Directors approved the buyback program on November 28, 2025, with the company appointing Mefcom Capital Markets Limited as the manager to oversee the buyback process. The program targets up to 5,80,000 equity shares at a maximum price of ₹330.00 per share.

Regulatory Compliance and Publication

Pursuant to Regulation 24(vi) of the SEBI Buyback Regulations, Nureca Limited published its post-buyback public announcement dated December 31, 2025, in multiple newspapers on January 1, 2026. The announcement ensures compliance with regulatory disclosure requirements.

Contact Information and Next Steps

The company has designated Ms. Nishu Kansal, Company Secretary & Compliance Officer, as the authorized contact person for buyback-related queries. Shareholders can reach her at +91 22 4961 6173 or nishu.kansal@nureca.com for further information or clarification regarding the buyback process.

The buyback will be conducted through the stock exchange mechanism on a proportionate basis for eligible shareholders as of the record date. This approach ensures fair participation opportunities for all qualifying shareholders while maintaining transparency in the process.